| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||
Net loss | ||||||||
-6,504 | -5,648 | -7,587 | -8,383 | -8,063 | -5,439 | -7,909 | -1,423 | -7,334 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | ||||||||
84 | 85 | 87 | 83 | 83 | 83 | 76 | 73 | 51 |
Stock-based compensation expense | ||||||||
477 | 489 | 535 | 536 | 450 | 375 | 428 | 352 | 503 |
Share of loss from equity method investment | ||||||||
-9 | - | - | -186 | -442 | - | - | - | - |
Change in fair value of preferred stock warrants | ||||||||
- | - | - | - | - | 0 | 1,389 | -3,059 | 38 |
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | ||||||||
- | 0 | -1,000 | 1,000 | -1,660 | - | - | - | - |
Other receivables | ||||||||
-153 | -187 | -848 | -693 | 1,703 | - | - | - | - |
Prepaid expenses | ||||||||
-1,141 | -172 | 772 | 786 | 47 | 1,047 | 600 | 264 | 296 |
Contract costs | ||||||||
488 | - | - | - | - | - | - | - | - |
Accounts payable | ||||||||
226 | -863 | 1,181 | -1,271 | 484 | - | - | - | - |
Accrued liabilities | ||||||||
328 | -202 | -779 | 2,077 | -1,098 | - | - | - | - |
Deferred revenue | ||||||||
- | 10,000 | 9,602 | 0 | -22 | -530 | -223 | -22 | 678 |
Accounts payable, accrued liabilities and other | ||||||||
- | - | - | - | - | - | - | - | 1,923 |
Net cash used in operating activities | ||||||||
-4,574 | 3,670 | 3,870 | -7,885 | -7,814 | -8,850 | -4,714 | -6,270 | -4,437 |
Cash flows from investing activities: | ||||||||
Purchase of property and equipment | ||||||||
13 | - | 26 | -93 | 120 | 323 | -242 | 647 | 272 |
Net cash used in investing activities | ||||||||
-13 | -121 | -26 | 93 | -120 | -1,000 | 242 | -647 | -272 |
Cash flows from financing activities: | ||||||||
Proceeds from stock option exercises | ||||||||
14 | 18 | 9 | 0 | 8 | - | - | - | - |
Net cash provided by financing activities | ||||||||
14 | 18 | 4,967 | 0 | 8 | - | - | - | - |
Net decrease in cash and cash equivalents | ||||||||
-4,573 | 3,567 | 8,811 | -7,792 | -7,926 | -9,840 | 20,607 | -6,917 | -4,709 |
Supplemental cash flow disclosures: | ||||||||
Cash paid for taxes | ||||||||
2 | 0 | 0 | 0 | 2 | - | - | - | - |
Supplemental noncash investing and financing activities: | ||||||||
Preferred stock dividends accrued | ||||||||
- | - | - | - | - | 0 | 5 | 535 | 817 |